Ovarian tumor growth regression using a combination of vascular targeting agents anginex or topomimetic 0118 and the chemotherapeutic irofulven

Por Dings, Ruud P.M., Van Laar, Emily S., Webber, Jeremy, Zhang, Yan, Griffin, Robert J., Waters, Stephen J., MacDonald, John R., Mayo, Kevin H.
Publicado em 2008